Acrivon Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.47

+0.08 (+5.76%)

As of Apr 1, 3:35 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 13 87%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target +2,798.6% upside

Low Target $22.54

Average Target $42.61

High Target $49.20

Current Price $1.47

Current
$1.47

Target
$42.61

$22.54 $42.61 avg $49.20

Scenario Analysis

Bear Case

$22.54

1,433.3%

Low target

Base Case

$42.61

+2,798.6%

Avg target

Bull Case

$49.20

+3,246.9%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$4.42

-66.7% from high

52-Week Low

$1.05

+40.0% from low

Target vs 52W High

$42.61

+864.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%